Dupilumab and Alopecia Areata

Name: Dupilumab and Alopecia Areata
Creator: Anagha Srivatsa
Published: 2025-05-07T14:41:52.290Z
Keywords: Dermatology, Drug, Alopecia Areata

Srivatsa, Anagha; Romanski, Madison; Rehman, Wasey; Graham, Shaveonte; Rehman, Rafey; Moossavi, Meena; Mehregan, Darius

doi:10.17632/wvycskd5v7.1

Dupilumab and Alopecia Areata

Published: 7 May 2025| Version 1 | DOI: 10.17632/wvycskd5v7.1

Contributors:

Anagha Srivatsa, Madison Romanski, Wasey Rehman, Shaveonte Graham, Rafey Rehman, Meena Moossavi, Darius Mehregan

Description

Some providers have used dupilumab off-label for the treatment of recalcitrant alopecia areata, particularly in patients with atopic dermatitis. However, many clinicians have noted mixed results, with some patients reporting improvement while other patients experiencing new-onset or worsening alopecia areata. The purpose of this systematic review was to investigate the clinical characteristics and outcomes in cases of dupilumab-treated and dupilumab-induced alopecia areata.

Dupilumab and Alopecia Areata

Description

Files

Categories

Licence